(Photo Credit: Allan Lewis / Schulich Medicine & Dentistry Communications)
Hitting a home run in the search for a cure for ALS
Arthur J. Hudson Chair in ALS Research Dr. Michael Strong and his team made a game-changing discovery toward a cure for amyotrophic lateral sclerosis (ALS), a neurodegenerative disease that leads to muscle wastage, paralysis and death. A generous $10-million gift from the Temerty Foundation will help the team bring its potential treatment to human clinical trials in five years – providing newfound hope to patients and their loved ones.
Read More
Life-changing implant
Thanks to an $8.5 million donation from global hearing implant company MED-EL, two new endowed research chairs – one in Neurotology and Translational Hearing Innovation and one in Auditory Biophysics and Engineering - were created. The inaugural chair holders, Dr. Sumit Agrawal and Hanif Ladak, PhD, are leaders in translational hearing science. The story received considerable exposure in local media and The Globe and Mail.
Read More
Navigating children’s health amid climate change
Schulich Medicine’s Dr. Anna Gunz was a sought-after expert, with several national media appearances, including an episode of CTV’s The Social, to share her thoughtful insights on how parents, guardians, educators and health-care providers can come together to navigate global warming and its devastating impacts on children’s health.
Read More
Closing in on an HIV treatment
The commitment and dedication to advancing innovative HIV/AIDS research at Schulich Medicine & Dentistry was recognized around the world and at home. Professor Eric Arts, PhD, BSc Honors’90, and his team found an effective and affordable targeted treatment strategy for an HIV cure – this study received international and national media coverage. Schulich Medicine researchers were interviewed for the Canadian Conference on HIV/AIDS Research that was held in London, Ont., highlighting their wide-ranging HIV research that leaps across disciplines.
Read More
Breaking down highly infectious diseases
As we witnessed a surge in deadly and invasive group A streptococcus cases and the sudden spread of H5N1 avian flu around the globe, Schulich Medicine & Dentistry experts shared preventative measures people can take to reduce risk of infection and helped people to understand the infectious diseases. John McCormick, PhD, and Jennifer Guthrie, PhD, shared valuable guidance regarding strep A. Guthrie also provided clarity to distill the complexities surrounding avian flu.
Read More
Levelling the playing field for dental care
As the federal government continues to roll out its new Canadian Dental Care Plan to make dental care more accessible and affordable, Schulich Dentistry’s Drs. Noha Gomaa and Carlos Quiñonez gave expert commentary in news outlets across the country to help Canadians understand this critical issue.
Read More
How much melatonin is too much?
How effective is phenylephrine in decongestant drugs? Is melatonin safe for kids? Dr. Michael Rieder shared his expertise on these topics in multiple print, TV and radio interviews after news broke about the ineffectiveness of some popular nasal decongestants and the high rate of parents using melatonin to help their kids sleep.
Read MorePrevious story
Next story
Invest in the future!
Take a minute to update your contact information so we can let you know about benefits, opportunities and events exclusive to alumni. And consider how you can support the next generation of leaders at Schulich Medicine & Dentistry.
